3Robert J, Glynn, Eleanor Panielson, et al. A randomized trial of rosuvas- tatin in the prevention of venous thromboembolism [J]. NEW Engl J Med,2009,360:1851-1860.
4Alberh F, Frick M, Sussenbacher A, et al. Effect of atovastatin on peripheral endothelial function and systemic inflammatory markers in patients with stable coronary artery disease [J]. Wien Med Wochenschr, 2007,157:73-78.
5Watanabe E, Arakawa T, Uchiyama T, et al. High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion [J]. Int J Cardiol,2006,108: 346-353.
6Angeli F, Reboldi G, Garofoli M, et al.Atrial fibrillation and mortality in patients with acute myocardial infarction: a systematic overview and meta-analysis[J].Current Cardiology Reports, 2012, 14 ( 5 ) : 601-610.
7Den R, Varosy P D.Invited commentary--global arrhythmia burden: the public health implications of the rise in atrial fibrillation comment on "the increasing burden of atrial fibrillation compared with heart failure and myocardial infarction" [J].Archives of Internal Medicine, 2012, 172 (9) : 741-742.
8Jabre P, Jouven X, Adnet F, et al.Atrial fibrillation and death after myocardial infarction a community study[J].Circulation, 2011, 123 ( 19 ) : 2094-2100.
9Jabre P, Roger V L, Murad M H, et al.Mortality associated with atrial fibrillation in patients with myocardial infarction clinical perspective: a systematic review and meta-analysis[J].Circulation, 2011, 123 (15): 1587-1593.
10Lamberts M, Olesen J B, Ruwald M H, et al.Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study[J].Circulatlnn,2012,126 ( 10 ): 1185-1193.
